Inspire Investing’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
Other funds holding HAE
AI
Inspire Investing's HAE Position: Q2 2026 in Review
Inspire Investing reduced its Haemonetics (HAE) stake by 1.1% in Q2 2026, selling an estimated $6.42K and leaving 8,999 shares worth $675K. The position accounts for 0.03% of the portfolio, ranked #840.
Inspire Investing first reported a position in HAE in Q4 2017 and has held it in 21 quarters since. The position peaked at $920K in Q2 2023. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.
- Inspire Investing held 8,999 shares of Haemonetics worth $675K as of Q2 2026.
- Inspire Investing sold 100 Haemonetics shares in Q2 2026, an estimated $6.42K.
- Haemonetics made up 0.03% of Inspire Investing's portfolio in Q2 2026, its #840 holding.
- Inspire Investing first reported a position in Haemonetics in Q4 2017 and has held it in 21 quarters since.
- Inspire Investing's Haemonetics position peaked at $920K in Q2 2023.
- 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.
Based on Inspire Investing's 13F filing for Q2 2026, filed 12 Aug 2026.